← back to search

J. Keith Joung

Harvard University · US
Area of research
Molecular Biology
Research interest
Research interests include CRISPR and Genetic Engineering, Advanced biosensing and bioanalysis techniques, RNA and protein synthesis mechanisms, and RNA Interference and Gene Delivery.
h-index
91
citations
56,816
works
240
NIH funding
primary concept
Biology
email

Recent publications

CRISPR PERSIST-On enables heritable and fine-tunable human gene activation
2024cited by 3position: contributordoi
MOSAIC enables <i>in situ</i> saturation mutagenesis of genes and CRISPR prime editing guide RNA optimization in human cells
2024cited by 1position: contributordoi
Engineered CRISPR prime editors with compact, untethered reverse transcriptases.
2023cited by 81position: contributordoi
Genetic predisposition to neuroblastoma results from a regulatory polymorphism that promotes the adrenergic cell state
Journal of Clinical Investigation 2023cited by 13position: middledoi
Genetic predisposition to neuroblastoma results from a regulatory polymorphism that promotes the adrenergic cell state.
2023cited by 9position: contributordoi
Genetic Predisposition to Neuroblastoma Results from a Regulatory Polymorphism that Promotes the Adrenergic Cell State
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 1position: middledoi
CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells.
2022cited by 169position: contributordoi
Multidimensional control of therapeutic human cell function with synthetic gene circuits
Science 2022cited by 149position: middledoi
Multidimensional control of therapeutic human cell function with synthetic gene circuits.
2022cited by 127position: contributordoi
Author Correction: CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells.
2022cited by 3position: contributordoi
Author Correction: Augmenting and directing long-range CRISPR-mediated activation in human cells.
2022cited by 0position: contributordoi
CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells.
2021cited by 415position: contributordoi
PrimeDesign software for rapid and simplified design of prime editing guide RNAs
Nature Communications 2021cited by 187position: middledoi
Optimization of AsCas12a for combinatorial genetic screens in human cells.
2021cited by 180position: contributordoi
PrimeDesign software for rapid and simplified design of prime editing guide RNAs.
2021cited by 146position: contributordoi
Defining genome-wide CRISPR-Cas genome-editing nuclease activity with GUIDE-seq.
2021cited by 72position: contributordoi
Scalable characterization of the PAM requirements of CRISPR–Cas enzymes using HT-PAMDA
Nature Protocols 2021cited by 50position: middledoi
Analysis of off-target effects in CRISPR-based gene drives in the human malaria mosquito
Proceedings of the National Academy of Sciences 2021cited by 43position: middledoi
A Code of Ethics for Gene Drive Research
The CRISPR Journal 2021cited by 42position: lastdoi
Augmenting and directing long-range CRISPR-mediated activation in human cells.
2021cited by 28position: contributordoi
Analysis of off-target effects in CRISPR-based gene drives in the human malaria mosquito.
2021cited by 27position: contributordoi
Global-scale CRISPR gene editor specificity profiling by ONE-seq identifies population-specific, variant off-target effects
2021cited by 8position: contributordoi
CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells
Nature Biotechnology 2020cited by 569position: lastdoi
Therapeutic base editing of human hematopoietic stem cells
Nature Medicine 2020cited by 279position: middledoi
A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing
Nature Biotechnology 2020cited by 242position: lastdoi
Optimization of AsCas12a for combinatorial genetic screens in human cells
Nature Biotechnology 2020cited by 240position: middledoi
A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing.
2020cited by 196position: contributordoi
PrimeDesign software for rapid and simplified design of prime editing guide RNAs
2020cited by 2position: contributordoi
PrimeDesign software for rapid and simplified design of prime editing guide RNAs
2020cited by 0position: contributordoi
CRISPResso2 provides accurate and rapid genome editing sequence analysis
Nature Biotechnology 2019cited by 1,792position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 22 papers (2019–2024)Shengdar Q. Tsai · St. Jude Children's Research Hospital19 papers (2012–2019)Deepak Reyon · Fidelity Biosciences (United States)17 papers (2012–2023)Benjamin P. Kleinstiver · Harvard University14 papers (2015–2021)Martin J. Aryee · Harvard University13 papers (2014–2020)Jeffry D. Sander · Corteva (United States)12 papers (2012–2022)Kendell Clement · Centre for Addiction and Mental Health8 papers (2018–2021)Jonathan Y. Hsu · Massachusetts Institute of Technology8 papers (2017–2021)Morgan L. Maeder · Editas Medicine (United States)8 papers (2013–2014)David R. Liu · Broad Institute7 papers (2013–2021)Nathalie T. Nguyen · University of Rochester Medical Center7 papers (2014–2018)Julian Grünewald · Massachusetts General Hospital7 papers (2019–2023)Jonathan Y. Hsu · Langley Research Center7 papers (2020–2024)Martin J. Aryee · Massachusetts Institute of Technology7 papers (2019–2022)Julian Grünewald · Center for Cancer Research6 papers (2019–2021)Vikram Pattanayak · Massachusetts General Hospital6 papers (2013–2021)Luca Pinello · Harvard University6 papers (2018–2021)Yanfang Fu · Hebei Medical University6 papers (2013–2018)Sara P. Garcia · Centro de Investigación Biomédica en Red de Cáncer6 papers (2018–2020)Karl Petri · Center for Cancer Research6 papers (2020–2023)